NEW YORK, Nov. 3, 2017 /PRNewswire/ -- Stull, Stull & Brody today announces it has commenced an investigation of BioDeliverySciences International, Inc. ("BioDelivery" or the "Company") (NASDAQ:BDSI) concerning possible violations of federal securities laws.
If you hold BioDelivery stock and you have questions about your legal rights or interests with respect to these
You may retain Stull, Stull & Brody, or other counsel of your choice, to represent you. Stull, Stull & Brody has litigated many class actions for violations of securities laws in federal courts over the past 40 years and has obtained court approval of substantial settlements on numerous occasions. Stull, Stull & Brody maintains offices in New York and Beverly Hills.
Attorney Advertising. Prior Results Do Not Guarantee A Similar Outcome.
View original content:http://www.prnewswire.com/news-releases/stull-stull--brody-announces-investigation-relating-to-potential-securities-law-violations-by-biodelivery-sciences-international-inc-nasdaqbdsi-300549568.html
SOURCE Stull, Stull & Brody
Subscribe to our Free Newsletters!
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...
Bronchopulmonary dysplasia or chronic lung disease of infancy is seen in premature and low birth ...
Ear, nose and throat are important organs and disease in one area can affect the others. ENT ...View All